US Patent 9169304 Process for purifying recombinant
Patent 9169304 was granted and assigned to Pfenex Inc on October, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+159 characters)
Article
Patent abstract
The present invention relates to processes for purifying high-quality recombinant Plasmodium falciparum circumsporozoite protein at high yields.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09169304 Process for purifying recombinant US Patent 9169304 Process for purifying recombinant
Infobox
Patent Number
091693040
Patent Number
91693040
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
091693040
Date of Patent
October 27, 2015
0Patent Application Number
138442610
Date Filed
March 15, 2013
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09169304 Process for purifying recombinant
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09169304
Date of patent
October 27, 2015
Patent application number
13844261
Date Filed
March 15, 2013
Patent primary examiner
Find more entities like US Patent 9169304 Process for purifying recombinant
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.